Ep. 172 - AACR Insights
BioCentury This Week
00:00
ABC Trials Outnumber New Maps
Trials of anybody drug conjugates outnumbered those of new maps. Just given the amount of excitement we've seen around ABCs over the past year or so with the in her to data in her to low breast cancer, with all of the deals that we've seen in recent months. You know, these are sort of a next generation version of of maps that use that antibody targeting potential to bring chemo therapies that would otherwise be to cytotoxic to use systemically to the tumor.
Transcript
Play full episode
